AnaptysBio, Inc. (ANAB)
45.95
-0.26
(-0.56%)
USD |
NASDAQ |
Oct 09, 16:00
46.00
+0.05
(+0.11%)
After-Hours: 20:00
AnaptysBio EPS Diluted (Quarterly) : 6.185 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.185 |
| March 31, 2026 | -1.843 |
| December 31, 2025 | 1.583 |
| September 30, 2025 | 0.5208 |
| June 30, 2025 | -1.341 |
| March 31, 2025 | -1.283 |
| December 31, 2024 | -0.7154 |
| September 30, 2024 | -1.137 |
| June 30, 2024 | -1.706 |
| March 31, 2024 | -1.639 |
| December 31, 2023 | -1.588 |
| September 30, 2023 | -1.405 |
| June 30, 2023 | -1.496 |
| March 31, 2023 | -1.583 |
| December 31, 2022 | -0.9285 |
| September 30, 2022 | -1.184 |
| June 30, 2022 | -1.154 |
| March 31, 2022 | -1.308 |
| December 31, 2021 | -1.182 |
| September 30, 2021 | -0.243 |
| June 30, 2021 | -0.0157 |
| March 31, 2021 | -0.6638 |
| December 31, 2020 | 1.204 |
| September 30, 2020 | -0.8701 |
| June 30, 2020 | -0.7899 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.303 |
| December 31, 2019 | -0.7462 |
| September 30, 2019 | -1.147 |
| June 30, 2019 | -0.8866 |
| March 31, 2019 | -0.8183 |
| December 31, 2018 | -0.6344 |
| September 30, 2018 | -0.6609 |
| June 30, 2018 | -0.569 |
| March 31, 2018 | -0.6338 |
| December 31, 2017 | -0.2972 |
| September 30, 2017 | -0.446 |
| June 30, 2017 | -0.1324 |
| March 31, 2017 | -0.7476 |
| December 31, 2016 | -0.2139 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.0446 |
| March 31, 2016 | -0.05 |
| December 31, 2015 | -0.1764 |
| September 30, 2015 | -0.0734 |
| June 30, 2015 | -0.0028 |
| March 31, 2015 | -0.0189 |
| December 31, 2014 | -0.0029 |
| September 30, 2014 | 0.036 |
| June 30, 2014 | 0.0384 |
| March 31, 2014 | -0.0599 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
| Imunon, Inc. | -0.5412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 229.24M |
| Revenue (Quarterly) | 27.49M |
| Total Expenses (Quarterly) | -201.75M |
| Enterprise Value | 1.471B |
| Earnings Yield | 14.03% |
| Operating Earnings Yield | 9.82% |
| Normalized Earnings Yield | 14.03 |